Human postnatal Mesenchymal Stem Cell Derived Islets as a Model for Diabetes Research.

Area of Science:

• Endocrinology
• Stem Cell Biology
• Regenerative Medicine

Background:

• Scarcity of human cadaver islets for transplantation in Diabetes Mellitus (DM) necessitates alternative sources.
• Stem cell-derived Islet-Like Clusters (ILCs) show potential for DM treatment and drug discovery.
• In vitro differentiation of ILCs mimics in vivo islet development but often results in immature cells.

Purpose of the Study:

• To review the utilization of ILCs from human postnatal tissues as an in vitro model.
• To discuss ILCs for cytotoxicity testing, drug screening, and enhancing transplantation efficacy.
• To explore ILCs as a platform for drug screening and stem cell-based DM treatment, particularly in regions with restrictions on cadaver islet research.

Main Methods:

• Review of current literature on stem cell-derived ILCs.
• Discussion of pharmacological preconditioning to improve ILC function.
• Analysis of ILC applications in drug screening and transplantation.

Main Results:

• Pharmacological preconditioning can enhance the in vitro and in vivo performance of ILCs.
• ILCs can serve as a reliable in vitro model for drug screening and cytotoxicity testing.
• ILCs offer a viable alternative to animal testing in drug discovery.

Conclusions:

• ILCs derived from human postnatal tissues are valuable for in vitro research and potential DM therapy.
• ILCs can complement, reduce, and potentially replace animal testing in drug screening.
• ILCs represent a significant advancement for in vitro screening and stem cell-based DM treatment, especially under research restrictions.